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Type 1 secretion systems (T1SS) catalyze the one
step protein transport across the membranes of
Gram-negative bacteria and are composed of an
outer membrane protein, a membrane fusion protein
and an ABC transporter. The ABC transporter
consists of the canonical nucleotide binding and
transmembrane domains. For the toxin hemolysin A
(HlyA), the ABC transporter HlyB carries an addi-
tional, N-terminal domain sharing about 40%
homology to C39 peptidases, but this ‘‘C39-like
domain’’ (CLD) is suggested to feature another, yet
unknown function. Our functional and structural
analysis demonstrates that the CLD is essential for
secretion and that it specifically interacts with the
unfolded state of HlyA. We determined the nuclear
magnetic resonance structure of the CLD as well as
the substrate-binding region within the CLD. This
mode of action, represents a mechanism within
T1SS and answers the question, how a large and
unfolded substrate is protected inside the cells
during secretion.
INTRODUCTION
Type 1 secretion systems (T1SS) are widespread among Gram-
negative bacteria (Delepelaire, 2004; Holland et al., 2005) and
catalyze the one step translocation of polypeptides across
both, the inner and outer membranes, directly to the exterior.
The transported substrates include toxins, lipases, heme-
binding, and S-layer proteins, which are presumably transported
in an unfolded state (Bakkes et al., 2010; Holland et al., 2005). A
paradigm of such substrates is hemolysin A (HlyA), a 110 kDa
large toxin of the repeat-in-toxins (RTX) superfamily that lyses,
for example, mammalian erythrocytes (Linggood and Ingram,
1982). The hallmark of HlyA and other RTX toxins are the RTX
domains that contain glycine- and aspartate-rich nonapeptide
repeats with the consensus sequence GGxGxDxUx (x, any
amino acid; U, large, hydrophobic amino acid), the so-called1778 Structure 20, 1778–1787, October 10, 2012 ª2012 Elsevier LtdGG repeats. Ca2+ ions are bound by these GG repeats with
high affinity, which triggers folding, most likely after secretion
of the T1SS substrate into the environment (Baumann et al.,
1993). Depending on the substrate, which is transported, the
number of GG repeats varies from less than 10 to more than
40 (Linhartova´ et al., 2010). Another characteristic of all T1SS
substrates is the C-terminal signal that is essential for secretion
and is not cleaved during or after secretion. In the case of HlyA, it
is encoded within the last 50–60 C-terminal amino acids (Ghigo
and Wandersman, 1994; Kenny et al., 1992, 1994). In the past,
a C-terminal fragment of HlyA, called HlyA1 (amino acids 807–
1024), has been used as a surrogate (Benabdelhak et al.,
2003). HlyA1 contains the C-terminal secretion signal, three
conserved GG repeats and is secreted as efficiently as HlyA.
Comparable to HlyA, Ca2+ ions induce the folding of such frag-
ments into a stable conformation (Sa´nchez-Magraner et al.,
2007, 2010).
In general, T1SS are composed of three membrane proteins,
an ATP-binding cassette (ABC) transporter, a membrane fusion
protein (MFP), and an outer membrane protein (Holland et al.,
2005). For the HlyA T1SS, these proteins are the ABC transporter
HlyB, the MFP HlyD and the outer membrane protein TolC (Kor-
onakis et al., 2000; Le´toffe´ et al., 1990). HlyB and HlyD form
a stable complex in the inner membrane and recruit TolC only
in the presence of the substrate HlyA (Thanabalu et al., 1998).
The functional complex forms a tunnel across the periplasm,
which guarantees the continuous translocation of likely unfolded
HlyA without any periplasmic intermediate (Bakkes et al., 2010;
Kenny et al., 1992; Koronakis et al., 2000; Thanabalu et al.,
1998). In the presence of the acyl carrier protein HlyC, two
specific lysine residues of HlyA are acylated prior to secretion,
converting non-toxic HlyA into the active HlyA (Stanley et al.,
1994). However, this posttranslational modification does not
influence the secretion process (Nicaud et al., 1985).
Canonical ABC transporters are composed of four modules,
two transmembrane domains (TMDs) and two nucleotide-
binding domains (NBDs). HlyB, however, contains an additional
N-terminal extension of 123 amino acids. Sequence alignments
revealed a homology of 42% to C39 peptidases, which are
cysteine proteases of the papain superfamily (Ishii et al.,
2010). C39 peptidases are N-terminal domains of ABC trans-
porters that usually transport antimicrobial peptides called
bacteriocins. In these systems, the C39 peptidase cleaves theAll rights reserved
Figure 1. Schematic View of the HlyA Constructs Used in This Study
with Corresponding, Calculated Molecular Masses and Extinction
Coefficients
(A) HlyA (UniProtKB entry Q1R2T5) contains an N-terminal, putative hydro-
phobic membrane insertion domain (M), a C-terminal secretion signal (blue)
and six RTX repeats of the consensus sequence GGxGxDxUx (x, any amino
acid residue, U, large, hydrophobic amino acid residue). The two indicated
lysine residues are acylated in toxic form of HlyA.
(B) The C-terminal fragment of HlyA, HlyA1, consists of the secretion signal,
three conserved RTX repeats and a modified RTX repeat (GGKDDKLSL).
(C) HlyA2 corresponds to HlyA1 devoid of the last 57 amino acid residues and
therefore the secretion signal.
Figure 2. Secretion Analysis of HlyA
Crude cell extracts were taken for SDS-PAGE analysis and subsequently
stained with CBB (lanes 2–4). The same cell extracts (lanes 5–7) and super-
natant samples (lanes 8 and 9) were used for western blotting using an anti-
body raised against HlyA. Lane 1, Molecular weight markers (in kDa); lanes 2
and 5, cells expressing only hlyA (110.5 kDa); lanes 3 and 6, cells expressing
hlyA, hlyB and hlyD; lanes 4 and 7, cells expressing hlyA,DCLD-hlyB and hlyD;
lane 8, supernatant sample of lanes 3 and 6; lane 9, supernatant sample of
lanes 4 and 7. The arrow indicates the position of HlyA.
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An ABC Transporter with Dual Functionprecursor peptide during secretion C-terminal to a conserved
stretch of 15 amino acids, the so-called GG motif. This stretch
is part of an N-terminal leader peptide and its removal produces
the mature bacteriocin (Dirix et al., 2004; Ha˚varstein et al., 1995;
Kotake et al., 2008; Wu and Tai, 2004). In the N-terminal exten-
sion of HlyB, however, the catalytic essential cysteine of C39
peptidases is absent. Moreover, HlyA does not contain an
N-terminal leader peptide or a GG motif and is not cleaved
during or after the transport. Obviously, the N-terminal domain
of HlyB does not fulfill an equivalent function and is therefore
called ‘‘C39-like domain’’ (CLD). The function of the CLD is
currently unknown.
Here, the CLD of HlyB was investigated in great detail by
biochemical and structural analysis. We demonstrate that the
presence of the CLD is essential to secrete HlyA and that the
CLD binds the RTX domain of HlyA1 exclusively in the unfolded
state. The solution structure of the CLD was solved by NMR
spectroscopy, which also allowed a precise mapping of the
substrate-binding region. Taken together, our results suggest
that the CLD tethers HlyA to prevent, for example, aggregation
of the secretion-competent, unfolded state. Obviously, the
ABC transporter HlyB carries an additional function besides
energizing substrate transport. It binds the substrate HlyA
through the CLD, a mechanism to recognize the unfolded
substrate in the cytosol. This might represent a general mecha-
nism of ABC transporters involved in the secretion of RTX
proteins and finally suggests how large, unfolded RTX toxins
are protected inside the cells. The function of the CLD might
also explain why no chaperone is known to be involved in
HlyA secretion and significantly enhances our understanding
of T1SS.Structure 20, 1778–1RESULTS
Purification of the CLD, HlyA, HlyA1, and HlyA2
The CLD was cloned, expressed, and purified as previously
described (Schwarz et al., 2011). HlyA and the C-terminal frag-
ments, HlyA1 (amino acids 807–1024) containing three highly
conserved RTX repeats and HlyA2 (amino acids 807–966),
were expressed and purified as previously described (Benabdel-
hak et al., 2003). HlyA2 (18 kDa) corresponds to the C-terminal
fragment HlyA1, but lacks the secretion signal. For a detailed
scheme of the constructs see Figure 1.
Secretion Analysis of HlyA in the Presence of HlyB
or DCLD-HlyB
Full-length HlyA (amino acids 1–1024) was produced in Escher-
ichia coli BL21 (DE3) (Figure 2, lane 2). Together with wild-type
(wt) HlyB and HlyD, HlyA was secreted to the supernatant (Fig-
ure 2, lane 8) and low levels remained inside the cells (Figure 2,
lanes 3 and 6). In cells producing HlyA in combination with
DCLD-HlyB and HlyD, no HlyA could be detected in the super-
natant (Figure 2, lane 9). Instead, HlyA accumulated inside the
cells (Figure 2, lane 4). In the wt and DCLD backgrounds, all
components of the secretion complex (HlyB, HlyD, and TolC)
were expressed in similar amounts and localized to the mem-
brane fractions of the cells (Figure 3). Thus, neither decreased
expression levels nor mislocalization of DCLD-HlyB were re-
sponsible for the secretion defect. Taken together, these results
demonstrate that the CLD of HlyB is essential for the secretion
of HlyA.
Intrinsic Tryptophan Fluorescence to Determine the
Folding State of HlyA1
The folding states of HlyA1, refolded in the presence of CaCl2 or
EDTA, were investigated using intrinsic tryptophan fluorescence
spectroscopy (Baka´s et al., 1998; Sa´nchez-Magraner et al.,
2007, 2010). HlyA1 contains a single tryptophan residue (amino
acid 914), which was used as intramolecular probe. The fluores-
cence signal of ‘‘unfolded’’ HlyA1 increases approximately
3-fold after the addition of 8 mM Ca2+ (Figure S1A available on-
line). In contrast, the fluorescence intensity of ‘‘folded’’ HlyA1 did
not change after the addition of Ca2+. Titration experiments re-
vealed a KD for the binding of Ca
2+ to unfolded HlyA1 of 230 ±
24 mM with a sigmoidal binding curve (h = 2.14 ± 0.40)787, October 10, 2012 ª2012 Elsevier Ltd All rights reserved 1779
Figure 3. Western Blots of Membrane Fractions after Secretion
Analysis of HlyA with HlyB and DCLD-HlyB, Respectively
HlyB (79.8 kDa), DCLD-HlyB (63.2 kDa), HlyD (56.5 kDa), and TolC (53.7 kDa)
are probed with polyclonal antibodies raised against each protein and de-
tected by immunofluorescence. TolC is expressed constitutively in E. coli.
Lanes 1, 3, and 6, HlyA T1SS components in the wild-type HlyB background;
lanes 2, 4, and 7, HlyA T1SS components in the DCLD-HlyB background; lane
5, molecular weight markers (in kDa). Note that HlyB and DCLD-HlyB migrate
below the expected molecular masses, which is often observed for membrane
proteins. The identity of HlyB andDCLD-HlyB were verified bywestern blotting
using a polyclonal HlyB antibody (data not shown). The higher molecular
weight form of HlyB may represent the dimer.
Figure 4. CBB Stained SDS-PAGE of Pull-Down Experiments with
Ni-NTA Beads between Purified HlyA1 and the CLD
Lane 1: Molecular weight markers (in kDa); lane 2, unfolded His6-HlyA1; lane 3,
CLD; lane 4, supernatant after incubation of the immobilized, unfolded His6-
HlyA1 and the CLD in binding buffer; lane 5, supernatant after repeated
washing with binding buffer; lane 6, eluted fraction after incubation with
binding buffer supplemented with 300 mM imidazole; lane 7, eluted fraction of
an identical pull-down experiment, but with folded instead of unfolded His6-
HlyA1. Note, equal volumes of the CLD sample were loaded on lanes 3 and 4.
The folding state of His6-HlyA1 was investigated in detail and the results are
presented in Figure S1. See also Figure S2 for a pull-down assay with the CLD
and unfolded HlyA.
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studies (Sa´nchez-Magraner et al., 2007, 2010) and indicate
that the two purification protocols specifically yielded the soluble
form of unfolded and folded HlyA1.
Pull-Down Assays of the CLD with HlyA, HlyA1, and
HlyA2
Since HlyA was expressed in similar amounts in the wt and the
DCLD background (Figure 2), one can exclude that the CLD influ-
ences the expression of HlyA. Therefore, a potential interaction
of the CLD with HlyA was investigated by pull-down assays (Fig-
ure S2). His10-CLD was immobilized and incubated with
unfolded HlyA. After extensive washing, both HlyA and the
CLD coeluted (Figure S2, lane 6), indicating a specific interaction
between both proteins. As the characteristic feature of RTX
toxins are the GG repeats, we suspected an interaction site
within the RTX domain and purified HlyA1 (24.7 kDa), which
contains three conserved GG repeats (Figure 1), in either an
unfolded or folded state (Benabdelhak et al., 2003; Holland
et al., 2005) (for a description of the folding experiments, see
Supplemental Information). Unfolded His6-HlyA1 was immobi-
lized and the pull-down assaywas repeatedwith theCLD lacking
the His10-tag. The CLD coeluted with unfolded HlyA1 (Figure 4,
lane 6) indicating an interaction. Since HlyA is presumably trans-
ported in an unfolded state (Bakkes et al., 2010), a possible influ-1780 Structure 20, 1778–1787, October 10, 2012 ª2012 Elsevier Ltdence of the folding state on the interaction with the CLD was
investigated. Pull-down experiments were repeated with folded
HlyA1 and, in contrast to the results with unfolded HlyA1, the
CLD did not coelute (Figure 4, lane 7). This indicates an interac-
tion of the CLD with the unfolded state of the substrate. To
confirm the RTX domain as binding partner of the CLD, pull-
down experiments were repeated with HlyA2 (HlyA1 lacking
the secretion signal). As in the case of HlyA1, HlyA2 and the
CLD coeluted (Figure 5, lane 5). Since nonspecific binding of
either HlyA, HlyA1, HlyA2, or the CLD to the Ni-NTA beads was
not observed in the corresponding control experiments, these
data demonstrate an interaction of the CLD with the unfolded
domain of HlyA1 upstream of the secretion signal and within
the RTX domain.
NMR Structure of the CLD
Sequence alignments of the CLD indicated a similarity to C39
peptidases. Since the CLD interacts with the unfolded RTX
domain of HlyA and HlyA1, the biological function seems to differ
from that of C39 peptidases, which cleave the N-terminal leader
peptide from dedicated substrates behind the GG motif. To
understand this difference on a structural level, we determined
the solution structure of the isolated CLD by NMR spectroscopy
(PDB entry 3zua; see Table 1 for experimental restraints and
ensemble statistics). The overall structure features a a+b-fold
and is similar to the C39 peptidase ComA-PEP (Ishii et al.,
2010) with a rmsd of 1.8 A˚ over 137 Ca atoms as calculated by
the SSM routine implemented in coot (Emsley et al., 2010). It
consists of a central, six-stranded, antiparallel b sheet core sur-
rounded by a helices (Figure 6A). The fold can be divided in two
subdomains (Figure S3A). Themajor domain contains the b sheet
core (b1–b6) supplemented by two small a helices (a4 and a5). The
smaller domain comprises three consecutive N-terminal
a helices (a1–a3) sitting on top of the major domain. A structural
superimposition of the CLD and ComA-PEP confirmed theAll rights reserved
Figure 5. CBB Stained SDS-PAGE of a Pull-Down Experiment with
Ni-NTA Beads between Purified HlyA2 and the CLD
Lane 1: His6-HlyA2; lane 2, CLD; lane 3, supernatant after incubation of the
immobilized, unfolded His6-HlyA2 and the CLD in binding buffer; lane 4,
supernatant after repeated washing with binding buffer; lane 5, eluted fraction
after incubation with binding buffer supplementedwith 300mM imidazole; lane
6, molecular weight markers (in kDa). Note equal volumes of the CLD sample
were loaded on lanes 2 and 3.
Table 1. Experimental Restraints and Ensemble Statistics of the
HlyB-CLD
Experimental Restraints








Hydrogen bond restraints 1
Proline isomer restraints 1
Number of NOE Upper Bound Violations
Violations >0.5 A˚ 15.5 (±5.4)
Violations >0.3 A˚ 26.6 (±8.4)
Violations >0.1 A˚ 93.5 (±14.9)
Deviations from Idealized Covalent Geometry
RMSD
Bonds (A˚) 0.0023 (±0.0000)
Angles (deg) 0.3539 (±0.0029)
Impropers (deg) 0.2742 (±0.0053)
Deviations from Experimental Restraints
Rmsd
NOE restraints (A˚) 0.0581 (±0.014)
Dihedral angle restraints (deg) 0.253 (±0.0176)




Heavy atoms 0.63 (±0.05)
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An ABC Transporter with Dual Functionreplacement of the catalytical essential cysteine (Wu and Tai,
2004) by a tyrosine (Tyr9) (Figure 6B). Compared to the catalytical
histidine of ComA-PEP (His96), the equivalent histidine of the
CLD (His83) is flipped by 180. The side chain of Tyr9 fills the re-
sulting gap and Arg82 occupies the structural equivalent position
of the histidine of the ComA-PEP (His96).
The dislocation of His83 in the CLD is stabilized via a p–p
stacking of the imidazole ring with the indole group of Trp77 (Fig-
ure 6B). His-Trp stacks are common motifs used to stabilize
proteins with an energy gain of up to 4 kJ/mol (Samanta et al.,
1999). This kind of arrangement has not been described for
members of the C39 peptidase or papain family, so far. Interest-
ingly, in all CLDs of ABC transporters this tryptophan residue is
conserved (Figure S4), suggesting that the observed His-Trp
stacking represents a general feature of CLDs.Mapping of the Substrate-Binding Region of HlyA
The pull-down experiments indicated an interaction of the CLD
with the unfolded RTX domain of HlyA and HlyA1. We used the
advantage of NMR spectroscopy to further characterize this
interaction by chemical shift perturbation (CSP) experiments
with (1H-15N)-HSQC spectra using HlyA2. At the lowest molar
ratios between HlyA2 and the CLD (0.03 and 0.1:1), only slight
effects on the chemical shifts were observed, whereas signifi-
cant changes in the 1H and 15N frequencies of distinct correlation
signals were detected at the higher molar ratios (0.3 and 1:1)
(Figure 7). These changes cluster in sheets b3–b5 and helix a1.
The central part of the interaction surface is comprised of hydro-
phobic amino acids (around Ile15 and Leu96), surrounded by
a hydrophilic rim located on sheet b5, on helix a1 and in loop
l34 (Figure 7). The other amino acids of the CLD did not undergo
changes in chemical shifts, demonstrating the specificity of the
interaction. The CSP experiments were also carried out at
different Ca2+ concentrations (1–5 mM), starting from the
HlyA2-CLD complex in the absence of Ca2+. With increasing
Ca2+ concentrations, the cross peaks clearly shifted back
toward the reference spectrum of unbound CLD (Figure S5).
These CSP experiments were consistent with the pull-downStructure 20, 1778–1assays described above and demonstrated that Ca2+ diminish
the interaction of the CLD and HlyA2. Importantly, the CSP
experiments suggested the binding region on the CLD for HlyA2.
Mutational Analysis of the HlyB-CLD
The above-described experiments indicated that the HlyA2
binding-region within the CLD is located on the opposite site of
the ligand-binding region of ComA-PEP. To validate the NMR
data, specific mutations were introduced into the HlyB-CLD
and their influence onto the secretion of HlyA was investigated.
Therefore, we chose the mutations L43W and Q59W, which
correspond to the mutations A51W and A67W in ComA-PEP.
These mutations are located in the binding site of ComA-PEP
and cause a drastic reduction in substrate binding and hydrolysis
(Ishii et al., 2010). In parallel, we constructed the mutants E15A,
I16A, Y20A, and F99A of HlyB, which are located on the opposite
site and whose chemical shifts changed significantly during the
CSP experiments with the CLD and HlyA2 (Figure 8A). With
wild-type HlyB and HlyB L34W/Q59W, the secretion levels of
HlyA are similar (Figure 8B). In contrast to Y20A, which did not
influence HlyB expression level, introduction of F99A changed
the expression level of HlyB (Figure 8C). However, the amounts787, October 10, 2012 ª2012 Elsevier Ltd All rights reserved 1781
Figure 6. NMR Structure of the HlyB-CLD
(A) Solution structure of the HlyB-CLD solved with NMR spectroscopy (PDB
entry 3zua). The protein contains a six-stranded, antiparallel b sheet core
(yellow) and five flanking a helices (blue). The overall structure of the HlyB-CLD
is very similar to that of ComA-PEP and adopts the characteristic fold of
papain-like proteases (Barrett and Rawlings, 2001). The N and C termini are
indicated. Secondary structure elements are labeled. See also Figure S3 for
a topology diagram of the CLD and a superimposition of ten lowest energy
NMR structures of the CLD.
(B) Structural superimposition of the catalytic site of ComA-PEP (PDB entry
3k8u, green) and the equivalent site in the HlyB-CLD (orange). Both structures
superimpose with a RMSD of 1.8 A˚ over 137 Ca atoms. Amino acid residues of
the active center are shown in ball-and-stick representation and are labeled.
Figure S4 shows a sequence alignment of C39 peptidases and CLDs.
Structure
An ABC Transporter with Dual Functionof secreted HlyA in the F99Amutant seemed to be reducedmore
than the expression level of HlyB F99A. Importantly, the Y20A
mutation did not influence HlyB expression, but drastically
reduced HlyA secretion. This mutational analysis strongly
supports the results of the CSP experiments and suggests that
C39 peptidase domains and CLDs use different binding modes
for their cognate substrates.
DISCUSSION
The crystal structures of two members of the RTX toxin super-
family demonstrated that GG repeats bind Ca2+ ions (Baumann
et al., 1993; Hamada et al., 1996), which are essential for activity
(Ostolaza and Gon˜i, 1995; Ostolaza et al., 1995; Rose et al.,
1995). Recent studies also showed that C-terminal fragments
of HlyA bind Ca2+ ions with similar affinities as full-length HlyA
(K0.5 z100 mM), which induce their folding (Sa´nchez-Magraner
et al., 2007, 2010). Since the cytoplasmic Ca2+ concentration
in E. coli is very low (low mM range), whereas the extracellular
concentration is typically in the mM range, HlyA is suggested
to be transported in an unfolded state before Ca2+ ions trigger
the folding at the exterior (Chang et al., 1986; Holland et al.,
1999; Jones et al., 1999). As the CLD interacts exclusively with
the unfolded substrate, a cytoplasmical localization of the CLD
can be assumed. This localization is supported by recent studies
of the ABC transporter NukT, which transports the bacteriocin
nukacin. Here, the C39 peptidase domainwas shown to be local-
ized at the cytoplasmical site (Nishie et al., 2011). The exclusive
interaction of the CLD with the unfolded RTX domain also
suggests a participation of the GG repeats in the interaction
and Ca2+-induced conformational changes of the GG repeats1782 Structure 20, 1778–1787, October 10, 2012 ª2012 Elsevier Ltddiminish the interaction. Since all RTX proteins are characterized
by GG repeats, these sequence motifs represent a potential
candidate for the binding motif of the CLD in HlyA.
So far, no structural information is available for CLDs and only
the crystal structure of oneC39 peptidase, ComA-PEP, has been
described in the literature (Ishii et al., 2010). Here, we report the
solution structure of the HlyB-CLD determined by NMR spec-
troscopy. Despite a similar overall fold compared to the C39
peptidase ComA-PEP (Ishii et al., 2010), the CLD has a degener-
ated proteolytic site and revealed a p–p stacking, which might
be a characteristic feature of CLDs (Figure 9). This p–p stacking
also explains why a ‘‘simple’’ reintroduction of Cys at position 9
of the CLD (Y9C) does not restore proteolytic activity (data
not shown). Importantly, the binding site of HlyA2 is located
on the opposite side compared to the substrate-binding site
of ComA-PEP (Figures 7, 8, and S6). Despite the homology
between ComA-PEP and the CLD of HlyB and a resulting similar
overall structure, the CLD of HlyB represents a particular protein
class with a distinct binding site imposing specificity for the RTX
toxin HlyA.
Based on these findings, a sequence analysis of ABC trans-
porters containing either a C39 peptidase domain or a CLD
was performed and related to their dedicated substrates. Placed
in a phylogenetic tree, an unambiguous separation based on the
nature of the N-terminal domain emerged (Figure 9). All trans-
porters containing a C39 peptidase domain have rather small
substrates (<10 kDa). These belong to the bacteriocin family
that possess an N-terminal, cleavable leader peptide. In
contrast, ABC transporters with CLDs transport large substrates
(R55 kDa) that contain a C-terminal secretion signal and, impor-
tantly, are all members of the RTX toxin family. Thus, the exis-
tence of an RTX domain in the transported substrate is clearly
linked to the presence of a CLD in the cognate ABC transporter
(Figure 9). Moreover, this analysis allows now prediction of
substrates for ABC transporters, and vice versa, in newly
sequenced genomes. For example, the ABC transporter ClyB
from Enterococcus faecalis with unknown function contains
a C39 peptidase, and likely transports a bacteriocin with an
N-terminal leader peptide, whereas AqxB from Actinobacillus
equuli presumably transports a RTX toxin, as it harbors a CLD
(Figure 9).
Some ABC transporters dedicated to protein secretion in
Gram-negative bacteria are devoid of either a C39 peptidase
or a CLD and, therefore, do not match the described classes.
One such example is HasD, which is part of the HasA T1SS of
Serratia marcescens (Le´toffe´ et al., 1994; Masi and Wanders-
man, 2010). Since HasA is not cleaved during the transport
and contains no RTX domain, an N-terminal domain is absent
in HasD. Nevertheless, HasA contains primary recognition sites
that interact with HasD prior to the secretion. These sites,
however, do not correspond to any specific motif and their
precise identity remains to be defined (Masi and Wandersman,
2010). Interestingly, the chaperone SecB was shown to be
essential for the HasA T1SS by inhibiting the folding and main-
taining the unfolded, secretion-competent state of HasA (Dele-
pelaire and Wandersman, 1998). Previously, it was suggested
that a cytoplasmic chaperone of some kind is also required to
protect unfolded HlyA inside the cell (Holland et al., 2005);
however, no chaperone could be identified so far (HollandAll rights reserved
Figure 7. Interaction of HlyA2 with the CLD Characterized by NMR CSP Experiments
(A) Part of the (1H-15N)-HSQC spectra illustrating the CSP. Starting with an equimolar mixture of [NA]-HlyA2 and [U-15N]-CLD (75 mM), the CLD concentration was
kept constant, while HlyA2 was diluted in a three step series, each step reducing the HlyA2 concentration to a third. Arrows highlight the trajectory of chemical
shift changes.
(B) The chemical shift changes were mapped onto the CLD structure. Interacting regions are highlighted in yellow, while noninteracting regions are shown in blue.
(C) The chemical shift changes were mapped onto the primary sequence of the CLD. The main interface is formed by a1 and the complete b4–b6 segment (the red
and green lines indicate a cutoff of 1 or 2 s, respectively). In addition, Ca2+ was titrated to the HlyA2-CLD complex and the results are presented in Figure S5.
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An ABC Transporter with Dual Functionet al., 1990). Here, we provide strong evidence that the CLD of
HlyB fulfills this role. The CLD tethers HlyA to prevent its aggre-
gation and/or degradation during secretion. Therefore, HlyB
carries a dual function in the secretion process by energizing
the transport and shielding the RTX toxin. To our knowledge,
this mechanism is novel for T1SS and significantly expands the
understanding of protein transport across membranes.EXPERIMENTAL PROCEDURES
Cloning, Expression, and Purification of the CLD
The plasmid encoding the CLD was constructed from the parental plasmid
pET28b-HlyB by the introduction of a stop codon (TAA) at amino acid position
140 of wild-type HlyB. E. coli BL21 (DE3) pLysS was grown at 37C in medium
containing kanamycin (30 mg/ml) and chloramphenicol (30 mg/ml) under vigor-
ously shaking at 160 rpm. For biochemical experiments, 23 YT medium or for
isotopic enrichment M9 medium supplemented with 13C6-glucose (2 g/l;
99.9% CIL) and/or 15N-ammonium chloride (0.5 g/l; 99.9% CIL) was used.
The bacteria were grown to an OD600 of 0.6 before the expression of the
CLD was induced with 0.1 mM IPTG. Cells of a 4 L culture were harvestedStructure 20, 1778–14 hr after induction by centrifugation and resuspended in 60 ml buffer A
(10 mM Tris-HCl [pH 8.0], 150mMNaCl, 10mM imidazole, Complete Protease
Inhibitor Cocktail tablet; Roche). All subsequent steps were performed at 4C.
After the addition of DNase (0.1 mg/ml) and lysozyme (1.0 mg/ml), cells were
incubated for 20 min on ice and disrupted by three passages through a cell
disrupter (Constant Systems) at 2.5 kbar. The homogenate was centrifuged
for 30 min at 14,000 3 g and the supernatant was centrifuged again for 1 hr
at 120,000 3 g. The supernatant was applied to an immobilized metal-ion
affinity chromatography (IMAC) column (5 ml HiTrap Chelating HP column,
GE Healthcare), loaded with Ni2SO4 and equilibrated in buffer A. The CLD
was elutedwith a linear gradient from 10 to 500mM imidazole. Elution fractions
were immediately diluted 1:1 with buffer C (100 mM citrate, 50 mM LiCl, 2 mM
DTT [pH 6.0]) and concentrated by ultrafiltration using an Amicon Ultra Centrif-
ugal Filter device (10 kDaMWCO, Millipore). When required, His6-tagged TEV-
protease (Kapust et al., 2001) was used to remove the N-terminal His10-tag of
the CLD, resulting in an N-terminal overhang of Gly-Ala. TEV protease was
purified as described previously (Glu¨ck et al., 2009) and the digestion was per-
formed during dialysis against digestion buffer (50mMTris-HCl, 150mMNaCl,
2 mM DTT [pH 8.0]). After a second dialysis against digestion buffer without
DTT, the His6-TEV protease and the released His10-tag were removed by an
additional IMAC step and the flow through, containing the untagged CLD,
was collected and concentrated. A homogenous sample of the CLD was787, October 10, 2012 ª2012 Elsevier Ltd All rights reserved 1783
Figure 8. Comparison of the Predicted
Substrate Binding Region of the CLD and
ComA-PEP
(A) Cartoon representation of the NMR structure of
the CLD (gray). Residues forming the substrate-
binding interface of ComA-PEP are shown as
magenta surface. Leu43 and Gln59 of the HlyB-
CLD correspond to Ala51 and Ala67 in the ComA-
PEP (Ishii et al., 2010). Amino acids of the CLD that
displayed the largest changes in the CSP experi-
ments with HlyA2 are shown as green surface. The
amino acids that were mutated in this study are
indicated.
(B) Western blotting of supernatant samples after
secretion analysis with wild-type HlyB and
mutated HlyB using a polyclonal antibody raised
against HlyA. The HlyB mutations are indicated.
(C) Western blotting of cell lysates after the
secretion analysis of (B) with a polyclonal antibody
raised against HlyB. The surface electrostatic
potential of the CLD andComA-PEP are compared
in Figure S6.
Structure
An ABC Transporter with Dual Functionprepared by size-exclusion chromatography (SEC) using a Superdex 75 16/60
column (GE Healthcare) in buffer D (50 mM citrate, 50 mM LiCl, 5 mM DTT [pH
6.0]). Elution fractions containing the CLD were pooled, concentrated and
stored at 4C. For subsequent experiments, the CLD was dialyzed against
the appropriate buffer. The protein concentration was determined with a nano-
drop device (PeqLab) and the calculated molecular mass and extinction
coefficient.
Expression and Purification of HlyA
Nonacylated HlyA was purified as described previously from inclusion bodies
(Jumpertz et al., 2010). In brief, after washing of the IBs, HlyA was dissolved in
denaturation buffer (50 mM Tris-HCl, 8 M urea [pH 7.0]) and purified by anion-
exchange chromatography (DEAD fast flow Sepharose, GE Healthcare). HlyA
was eluted with a linear gradient from 0 mM to 300 mM NaCl in denaturation
buffer. Further purification steps were omitted. HlyA could be stored at 4C
for several months. Pull-down assays were performed with HlyA dialyzed
against denaturation buffer with 1.5 M Urea and 10 mM EDTA. The protein
concentration was determined with a nanodrop device (PeqLab) and the
calculated molecular mass and extinction coefficient (Figure 1).
Expression and Purification of HlyA1 and HlyA2
The C-terminal fragments of HlyA, HlyA1 (amino acid residues 807–1024,
24.9 kDa) and HlyA2 (amino acid residues 807–966, 17.7 kDa) were both puri-
fied as described previously (Benabdelhak et al., 2003). HlyA1 forms inclusion
bodies, which were purified, whereas HlyA2 represents a soluble degradation
product of HlyA1 devoid of the last 57 amino acid residues and, therefore, the
secretion signal. The introduction of an N-terminal His6-tag allowed the prep-
aration of pure proteins after an IMAC for HlyA1, and after an IMAC in combi-
nation with an anion-exchange chromatography for HlyA2. E. coli BL21 (DE3)
was grown in 2 3 YT medium at 37C to an OD600 of 1.0, induced with 4 mM
arabinose and harvested after 90min of cell growth. Cells were resuspended in
lysis buffer (10mMTris-HCl [pH 8.0], 100mMKCl, 1mMPMSF, 0.2 mMEDTA,
10%glycerol) and broken by three passages through a cell disrupter (Constant
Systems) at 2.5 kbar. The insoluble fraction was collected, dissolved in 25 ml
lysis buffer with 6 M guanidinium-HCl and dialyzed exhaustively against lysis
buffer containing 1 mM PMSF and either 0.2 mM EDTA (‘‘unfolded’’ HlyA1)
or 10 mM CaCl2 (‘‘folded’’ HlyA1), respectively. The soluble fraction after cell
disruption was centrifuged for 1 hr at 120,000 3 g at 4C to remove debris.
Both HlyA fragments were loaded onto HiTrap Chelating HP columns (GE
Healthcare) loaded with Ni2SO4 and equilibrated in lysis buffer containing
10 mM imidazole. Proteins were eluted with a linear gradient from 10 mM to
500 mM imidazole. Fractions with the HlyA fragments were pooled and
concentrated. HlyA1 was stored in lysis buffer with 25% glycerol at –80C.1784 Structure 20, 1778–1787, October 10, 2012 ª2012 Elsevier LtdIn addition to the described purification protocol (Benabdelhak et al., 2003),
HlyA2 was further purified via anion-exchange chromatography using a HiTrap
Q HP column (GE Healthcare), equilibrated in lysis buffer without KCl. HlyA2
was eluted with a linear gradient from 0 to 500 mM KCl. Fractions containing
pure HlyA2 were pooled, concentrated, and stored in lysis buffer with 25%
glycerol at –80C. Protein concentrations were determined with a nanodrop
device (PeqLab) and the calculated molecular masses and extinction coeffi-
cients (Figure 1).
Secretion Analysis of HlyA in the Presence of Wild-type HlyB, DCLD-
HlyB, or HlyB with Mutants within the CLD of HlyB
Plasmid pK184-HlyBD was mutated by site-directed mutagenesis using the
appropriate oligonucleotides at the positions E15A, I16A, Y20A, and F99A
and two point mutations were inserted iteratively at position L43W and
Q59W. E. coli BL21 (DE3) harboring plasmids pSU2726 (encoding for HlyA)
and either pK184-HlyBD, pK184-DCLD-HlyBD or mutated pK184-HlyBD
versions was grown at 37C in the presence of ampicillin (100 mg/ml) and kana-
mycin (30 mg/ml) (Bakkes et al., 2010; Jumpertz et al., 2010). The expression
was induced at an OD600 of 0.5 with 1 mM b-D-thiogalactopyranoside. After
4 hr growth, cultures were centrifuged for 10 min at 13,2003 g, 4C. Superna-
tant samples were taken for SDS-PAGE analysis and subsequent CBB staining
or immunoblotting using antibodies raised against HlyA. Cells were broken
with a cell disrupter (Constant Systems) and cell debris were removed by
centrifugation for 20 min at 14,000 3 g, 4C. The soluble fraction was centri-
fuged for 90 min at 120,0003 g, 4C and the pellet was analyzed by immuno-
blotting with antibodies raised against HlyB, HlyD, and TolC, respectively.
Intrinsic Tryptophan Fluorescence of HlyA1
Measurements were performed with 1 mM HlyA1, refolded either in the pres-
ence of 0.2 mM EDTA (‘‘unfolded’’ HlyA1) or 20 mM CaCl2 (‘‘folded’’ HlyA1)
at a Fluorolog III spectrometer (Horiba). After excitation (295 nm, 2 nm slit
width), the emission spectrum was recorded (310–360 nm, 6 nm slit width,
0.3 s integration time) before and after the addition of 8mMCaCl2. The normal-
ized fluorescence was plotted against the wavelength. For titration experi-
ments, Ca2+ was added gradually, fluorescence signals from 325–333 nm
were averaged, normalized and plotted against the Ca2+ concentration. Data
evaluation was done with the software Prism (GraphPad Software, Inc.) using
a nonlinear regression (one site – Specific binding with Hill slope).
Pull-Down Assays
His10-CLD and HlyA
Fifty microliter magnetic Ni-NTA beads (QIAGEN, Hilden) were equilibrated
three times with interaction buffer (0.5 M urea, 150mMNaCl, 20 mM imidazoleAll rights reserved
Figure 9. Phylogenetic Tree of ABC Transporters with C39 Pepti-
dases or CLDs
ABC transporters with C39 peptidases are shown in the continuous ellipse,
ABC transporters with CLDs are encircled with a dashed ellipse. All ABC
transporters with CLDs transport substrates of the RTX toxin family, whereas
ABC transporters with C39 peptidases transport bacteriocins. The dedicated
ABC transporter-substrate pairs are: ApxIIIB (UniProtKB entry Q04473) and
ApxIIID, NukT (UniProtKB entry Q75V16) and Nukacin, CvaB (UniProtKB entry
P22520) and Colicin V, ClyB (UniProtKB entry Q57403) and unknown, LagD
(UniProtKB entry P59852) and LagA, LtnT (UniProtKB entry O87239) and
cytolysin B, ComA (UniProtKB entry P59653) and ComC, HlyB (UniProtKB
entry Q1R2T6) and HlyA, LktB (UniProtKB entry P23702) and LktA, PaxB
(UniProtKB entry Q9RCG7) and PaxA, RtxB (UniProtKB entry A1YKX0) and
RtxA, AqxB (UniProtKB entry Q8KWZ8) and unknown. See also Figure S4 for
a sequence alignment of C39 peptidases and CLDs.
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An ABC Transporter with Dual Function[pH 8.0]) and 30 mg His10-CLD were immobilized. The beads were washed
three times with interaction buffer to remove unbound His10-CLD. Unfolded
HlyA was added to the beads (50 ml, 5.3 mg/ml) and gently mixed for 15 min
at room temperature before washing of the beads seven times with 100 ml of
interaction buffer. His10-CLD was eluted with elution buffer (interaction buffer
supplemented with 500mM imidazole). The same procedure was performed in
the absence of the His10-CLD to investigate non-specific binding of HlyA to the
beads.
His6-HlyA1/A2 and the CLD
Fifty microliter magnetic Ni-NTA beads (QIAGEN, Hilden) were equilibrated
with binding buffer (20 mM HEPES, 150 mM NaCl, 20 mM imidazole
[pH 7.0]) and 30 mg His6-HlyA1 were immobilized. In pull-down assays with
folded His6-HlyA1, buffers were supplemented with 20 mM CaCl2. Beads
were washed three times with binding buffer to remove unbound His6-
HlyA1. The CLD was added to the beads (40 ml, 2.0 mg/ml) and gently mixed
for 15 min at room temperature, before the beads were washed seven times
with 100 ml of binding buffer. His6-HlyA1 was eluted with 30 ml of elution buffer
(binding buffer supplemented with 300 mM imidazole). The same procedure
was performed in the absence of His6-HlyA1 to investigate nonspecific binding
of the CLD to the beads. Pull-down assays with His6-HlyA2 and the CLD were
performed identically.
NMR Spectroscopy
NMR experiments were performed at 303 K on a Varian VNMRS spectrometer
at a proton frequency of 900 MHZ with a cryogenically cooled triple resonanceStructure 20, 1778–1probe. Protein samples contained [U-15N]- or [U-15N,13C]-CLD in a buffer
system of 100 mM citrate (pH 6.0), 100 mM LiCl, 10 mM dithiotreitol,
0.5 mM EDTA, 0.05% (w/v) sodium azide, and 7% (v/v) D2O, at a protein
concentration of 2.5 mM. Precise procedures applied for NMR experiments,
data evaluation, and structure calculation are described in greater detail in
Supplemental Information.
NMR Titrations
CSP experiments were carried out to characterize the interaction between
HlyA2 and the CLD. Briefly, a series of (1H-15N)-HSQC spectra was recorded,
keeping the CLD concentration constant, while HlyA2 was diluted into the
sample. Starting from an equimolar sample of [U-15N]-CLD and [NA]-HlyA2
at 75 mM in titration buffer (25 mM Tris-HCl [pH 7.0], 125 mM NaCl, 2 mM
dithiotreitol, 0.5 mM EDTA, 7% (v/v) D2O), a three step dilution series with
a solution of 75 mM [U-15N]-CLD in titration buffer was set up, each step
reducing the HlyA2 concentration to a third. This resulted in protein-protein
ratios of 1:1, 1:0.3, 1:0.1, and 1:0.03 with a constant CLD concentration of
75 mM. In order to evaluate the effect of the folding state of HlyA2 in NMR
experiments, equimolar samples of the two proteins at 75 mM containing 0,
1, and 5 mM CaCl2 were prepared and (
1H-15N)-HSQC spectra recorded.
The CSP data was analyzed with CcpNmr analysis (Vranken et al., 2005).
Cross peaks were assigned using the deposited chemical shifts (BMRB entry
17403) (Lecher et al., 2011). Deviations due to differences in buffer conditions
were corrected by selecting to the closest neighboring cross peak, if the selec-
tion was unambiguous. Trajectories following the cross peak movement were
calculated and plotted against the residue numbers.
ACCESSION NUMBERS
The PDB accession number for the structure of the CLD of HlyB reported in this
paper is 3zua.
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